Professor of Pathology University of Chicago, Pritzker School of Medicine Chicago, Illinois, United States
Disclosure(s):
Mark Lingen, DDS, PhD: No financial relationships to disclose
Meet the emerging cancer threat reshaping your screening role. Human Papillomavirus (HPV)-associated squamous cell carcinoma of the head and neck region is now the most common HPV-related malignancy in the United States, with incidence rising dramatically and expected to climb for years to come. This evidence-based lecture examines the evolving etiologic and demographic features of this disease, emphasizing the critical role dental professionals play in early detection and cancer screening. Discover novel therapeutic options under development that specifically target HPV-associated neoplasms. Understand the epidemiologic trends, recognize at-risk populations and gain the screening expertise and patient communication strategies that position you as a vital frontline defense against this rising cancer threat.
Learning Objectives:
Distinguish the etiologic factors associated with squamous cell carcinoma of the oral cavity and oropharynx.
Articulate the role of the dental professional in screening for squamous cell carcinomas of the oral cavity and oropharynx.
Summarize the novel therapeutic strategies under development for the treatment of HPV-associated oropharyngeal squamous cell cancer.
.jpg "Mark Lingen, D.D.S., Ph.D. (he/him/his) photo")